$1 Trial Offer - Realtime Screener -- Try out our Realtime Product, GetStockIdeas. The advanced screener tool is a momentum trader's dream!
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
Loading PSDV News...
Health Technology » Biotechnology
|GILD||Gilead Sciences, Inc.||-1.19%||80.50||1.6%||$976.12m|
|REGN||Regeneron Pharmaceuticals, Inc.||-3.65%||405.25||3.4%||$314.78m|
|BMRN||BioMarin Pharmaceutical Inc.||-4.33%||95.13||3.6%||$203.41m|
|ALXN||Alexion Pharmaceuticals, Inc.||-3.86%||132.12||2.6%||$194.53m|
|VRTX||Vertex Pharmaceuticals Incorporated||-4.24%||96.71||2.3%||$119.75m|
|EXAS||Exact Sciences Corporation||-7.15%||18.97||30.9%||$116.17m|
|IONS||Ionis Pharmaceuticals, Inc.||-6.14%||31.64||11.1%||$95.68m|
|A||Agilent Technologies, Inc.||-2.32%||46.71||0.9%||$91.68m|
pSivida Corp. develops tiny, sustained-release products, which are designed to deliver drugs and biologics at a controlled and steady rate for weeks, months or years. The company through its technology platforms Duraser and BioSilico is focused on treatment of chronic diseases of the back of the eye and are also exploring applications outside ophthalmology. It is also developing a bioerodible, injectable micro-insert delivering latanoprost to treat glaucoma and ocular hypertension. pSivida was founded by Roger Aston in March 2008 and is headquartered in Waterson, MA.